ESC Premium Access

Decline over the years in the risk of cardiovascular events in patients with clinical manifest vascular disease is explained by change in cardiovascular risk factors and atherosclerotic burden.

Congress Presentation

About the speaker

Mr Gijs Berkelmans

University Medical Center Utrecht, Utrecht (Netherlands (The))
0 follower

4 more presentations in this session

State of the art in lipoproteins: lessons from real life registries

Speaker: Professor B. Nordestgaard (Copenhagen, DK)


Utility of ApoB target over LDL-C and non-HDL-C targets: insights from the national health and nutrition examination survey (NHANES) 2011-2012

Speaker: Doctor S. Martin (Baltimore, US)


Lipoprotein (Lp) (a) does not predict recurrent cardiovascular events in patients with stable coronary heart disease: 13-Year follow-up of the KAROLA study

Speaker: Professor W. Koenig (Munich, DE)


Future direction for research in lipids.

Speaker: Professor E. Bruckert (Paris, FR)


Access the full session

Lipoproteins and real life: what the randomized clinical trials do not show us

Speakers: Mr G. Berkelmans, Professor B. Nordestgaard, Doctor S. Martin, Professor W. Koenig, Professor E. Bruckert

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb